Background
Stenosing tenosynovitis, frequently referred to as trigger finger, is a common condition characterized by decreased mobility of the tendon in the tendon sheath. The current standard therapy is corticosteroid injection or open surgical release. Percutaneous release is an emerging therapy of trigger finger. The purpose of this study is to evaluate the efficacy and complications of percutaneous release compared to steroid and surgical therapy.
Method
A Medline search was performed for all relevant articles describing the use of corticosteroid, surgical, or percutaneous therapy of trigger finger. This study includes all published data of trigger finger treatment from 1965 to 2010. The PubMed database of the National Center for Biotechnology Information, National Library of Medicine (Bethesda, Md), Medline, Cochrane review database, and Google Scholar were used to collect reports using the key words "trigger finger", "corticosteroid", "percutaneous release", "surgical release". All articles were reviewed for reports of clinical cases, complications, doses, number of digits and patients, previous therapy, operation time, outcome measure, success, follow-up, and study design. The difference of success rates between steroid injection, open surgical release, and percutaneous release were described using contingency tables and chi-square tests. 
Conclusion
Percutaneous release as a treatment of trigger finger has similar efficacy to open surgical release and is superior to steroid injection. It is associated with a decreased operating time and fewer complications.
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